Free Trial
→ Nobody's Asking Where The SpaceX Money Comes From (From Americas Gold Company) (Ad)tc pixel Free REVBW Stock Alerts

Revelation Biosciences (REVBW) Competitors

$0.0075 0.00 (-10.74%)
As of 03:23 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

REVBW vs. AIMDW, ALVOW, ARAV, ACABW, and RNA

Should you be buying Revelation Biosciences stock or one of its competitors? The main competitors of Revelation Biosciences include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Avidity Biosciences (RNA). These companies are all part of the "pharmaceutical products" industry.

How does Revelation Biosciences compare to Ainos?

Revelation Biosciences (NASDAQ:REVBW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation.

In the previous week, Revelation Biosciences had 1 more articles in the media than Ainos. MarketBeat recorded 1 mentions for Revelation Biosciences and 0 mentions for Ainos. Revelation Biosciences' average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company Overall Sentiment
Revelation Biosciences Neutral
Ainos Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revelation BiosciencesN/AN/AN/AN/AN/A
Ainos$124.16KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Revelation BiosciencesN/A N/A N/A
Ainos N/A N/A N/A

Summary

Revelation Biosciences and Ainos tied by winning 1 of the 2 factors compared between the two stocks.

How does Revelation Biosciences compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Revelation Biosciences (NASDAQ:REVBW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$586.32MN/AN/AN/AN/A
Revelation BiosciencesN/AN/AN/AN/AN/A

In the previous week, Revelation Biosciences had 1 more articles in the media than Alvotech. MarketBeat recorded 1 mentions for Revelation Biosciences and 0 mentions for Alvotech. Alvotech's average media sentiment score of 0.00 equaled Revelation Biosciences'average media sentiment score.

Company Overall Sentiment
Alvotech Neutral
Revelation Biosciences Neutral

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Revelation Biosciences N/A N/A N/A

Summary

Alvotech and Revelation Biosciences tied by winning 1 of the 2 factors compared between the two stocks.

How does Revelation Biosciences compare to Aravive?

Revelation Biosciences (NASDAQ:REVBW) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revelation BiosciencesN/AN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

In the previous week, Revelation Biosciences had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for Revelation Biosciences and 0 mentions for Aravive. Revelation Biosciences' average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company Overall Sentiment
Revelation Biosciences Neutral
Aravive Neutral

Company Net Margins Return on Equity Return on Assets
Revelation BiosciencesN/A N/A N/A
Aravive N/A N/A N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Aravive beats Revelation Biosciences on 2 of the 3 factors compared between the two stocks.

How does Revelation Biosciences compare to Atlantic Coastal Acquisition Corp. II?

Revelation Biosciences (NASDAQ:REVBW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk and media sentiment.

Company Net Margins Return on Equity Return on Assets
Revelation BiosciencesN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revelation BiosciencesN/AN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

In the previous week, Revelation Biosciences had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for Revelation Biosciences and 0 mentions for Atlantic Coastal Acquisition Corp. II. Revelation Biosciences' average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
Revelation Biosciences Neutral
Atlantic Coastal Acquisition Corp. II Neutral

Summary

Revelation Biosciences beats Atlantic Coastal Acquisition Corp. II on 1 of the 1 factors compared between the two stocks.

How does Revelation Biosciences compare to Avidity Biosciences?

Avidity Biosciences (NASDAQ:RNA) and Revelation Biosciences (NASDAQ:REVBW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk, dividends and media sentiment.

Revelation Biosciences has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. Revelation Biosciences' return on equity of 0.00% beat Avidity Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Avidity Biosciences-3,650.39% -44.92% -39.57%
Revelation Biosciences N/A N/A N/A

Avidity Biosciences presently has a consensus price target of $69.42, suggesting a potential upside of 437.73%. Given Avidity Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Avidity Biosciences is more favorable than Revelation Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avidity Biosciences
1 Sell rating(s)
12 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.32
Revelation Biosciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Revelation Biosciences has lower revenue, but higher earnings than Avidity Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avidity Biosciences$18.62MN/A-$322.30MN/AN/A
Revelation BiosciencesN/AN/AN/AN/AN/A

In the previous week, Avidity Biosciences and Avidity Biosciences both had 1 articles in the media. Avidity Biosciences' average media sentiment score of 0.00 equaled Revelation Biosciences'average media sentiment score.

Company Overall Sentiment
Avidity Biosciences Neutral
Revelation Biosciences Neutral

Summary

Avidity Biosciences beats Revelation Biosciences on 5 of the 8 factors compared between the two stocks.

Get Revelation Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for REVBW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding REVBW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

REVBW vs. The Competition

Export
MetricRevelation BiosciencesBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$451.91M$6.25B$11.77B
Dividend YieldN/A3.86%2.74%5.26%
P/E RatioN/A4.1429.2527.07
Price / SalesN/A6,879.71504.6873.43
Price / CashN/A13.1343.3053.90
Price / BookN/A77.749.676.69
Net IncomeN/A-$96.07M$3.55B$332.64M
7 Day PerformanceN/A0.71%1.70%2.01%
1 Month PerformanceN/A3.87%5.62%9.19%
1 Year PerformanceN/A48.54%34.42%39.59%

Revelation Biosciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
REVBW
Revelation Biosciences
N/A$0.01
-10.7%		N/AN/A$0.00N/AN/A10
AIMDW
Ainos
N/A$0.10
+20.1%		N/AN/A$0.00$124.16KN/A40
ALVOW
Alvotech
N/A$0.25
-10.7%		N/AN/A$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:REVBW) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
The $1.75T "Backdoor" ticker (NOT Starlink)
When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...
Behind the Markets | Sponsoredtc pixel
URGENT: $2 Gold Stock With Major Discovery
A $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...
Paradigm Press | Sponsoredtc pixel